1.Clinical research on expression levels of T lymphocytes and NK cells in patients with esophageal cancer treated with radiotherapy
Zhongming WANG ; Guirong LIU ; Guanhong HUANG ; Jianxin MA ; Xiaolin LIU ; Dandan CHEN ; Chan ZHOU ; Chunluan YUAN ; Xiucui LI
Cancer Research and Clinic 2011;23(10):674-677
Objective To study the relationship between the change of T lymphocyte subsets and NK cells in esophageal cancer patients and radiotherapy effect.Methods The levels of T lymphocyte subsets and NK cells were detected by flow cytometry in 56 cases with histologically confirmed esophageal cancer treated with radiotherapy and contrasted to the healthy people.Results In patients with esophageal cancer,peripheral blood T cells,Th cells,Th / Ts were decreased significantly compared with the control group [(58.3±5.2) % vs (65.8±7.2) %,(28.7±5.0) % vs (38.1±7.7) %,(1.0±0.3) vs (1.6+2.7),all P < 0.05],while the Ts cells were significantly increased [(28.8±5.3) % vs (25.4±5.7) %,P < 0.05].There was no significant difference between peripheral blood T lymphocyte subsets,Th/Ts ratio change and patient age,sex,tumor staging,histological differentiation and pathological lesions.After radiotherapy,the levels of peripheral blood T cells,Th cells,Th/Ts cell ratio and NK cells in esophageal cancer patients were increased [(66.9±4.5) % vs (59.4±4.9) %,(40.6±5.6) % vs (29.1±4.2) %,(1.6+0.5) % vs (1.0±0.4) %,(16.2±3.9) % vs (14.6±3.2) %,all P < 0.05],while the Ts cells decreased [ (25.4±3.6) % vs (28.4±5.7) %,P < 0.05].The increasing degree of peripheral blood T cells,Th cells were closely related to the lesion progress,the difference was significant (both P < 0.05).Conclusion Cellular immune function in patients with esophageal cancer is low.Detection of T lymphocyte subsets,NK cells can be used for immune monitoring of patients with esophageal cancer.
2.Expression and clinical significance of FSTL3 protein in lung adenocarcinoma
Zhenghong LIU ; Chunluan YUAN ; Jia GAO
Journal of Clinical Surgery 2024;32(11):1166-1169
Objective To investigate the expression of Follistatin-like 3(FSTL3)protein in lung adenocarcinoma(LUAD)tissue and its association with clinical pathological indicators and prognosis.Methods A total of 268 LUAD patients who underwent radical resection of lung cancer were collected,and the expression of FSTL3 protein in LUAD and paired paracancerous normal tissues was detected using immunohistochemistry.The clinical pathological indicators and overall survival(OS)rate were compared among patients with different levels of FSTL3 expression.Cox regression model was used to analyze the influencing factors of postoperative OS in LUAD patients.Results The high expression rate of FSTL3 protein in LUAD tissue(55.97%)was significantly higher than that in paracancerous tissues(33.21%)(x2=28.098,P<0.001).The expression level of FSTL3 protein showed significant differences among LUAD patients with different degrees of differentiation,lymph node metastasis,distant metastasis,and TNM stage(all P<0.05).The OS rate of patients with high FSTL3 protein expression was significantly lower than that of patients with low expression(x2=4.706,P=0.030).Cox regression analysis indicated that lymph node metastasis,distant metastasis,TNM stages Ⅲ,and high expression of FSTL3 were independent risk factors affecting postoperative OS in LUAD patients(all P<0.05).Conclusion The expression of FSTL3 protein significantly increased in LUAD tissue,and it was associated with tumor differentiation,lymph node metastasis,distant metastasis,and TNM stage.High expression of FSTL3 was an independent risk factor affecting the postoperative prognosis of LUAD patients.FSTL3 protein has the potential to become a biomarker for early diagnosis and prognostic prediction of LUAD.